Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypersensitivity | 1 | 2017 | 5 | 0.510 |
Why?
|
| Metal-on-Metal Joint Prostheses | 1 | 2017 | 5 | 0.510 |
Why?
|
| Metals | 1 | 2017 | 9 | 0.510 |
Why?
|
| Knee Prosthesis | 1 | 2017 | 14 | 0.510 |
Why?
|
| Hip Prosthesis | 1 | 2017 | 60 | 0.500 |
Why?
|
| Arthralgia | 1 | 2017 | 25 | 0.500 |
Why?
|
| Osteocytes | 3 | 2014 | 14 | 0.270 |
Why?
|
| Vitallium | 2 | 2011 | 8 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 30 | 0.160 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2017 | 52 | 0.160 |
Why?
|
| Sex Factors | 1 | 2017 | 72 | 0.130 |
Why?
|
| Pain Measurement | 1 | 2017 | 54 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2017 | 32 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2017 | 34 | 0.120 |
Why?
|
| Young Adult | 1 | 2017 | 187 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2017 | 167 | 0.120 |
Why?
|
| Middle Aged | 2 | 2017 | 792 | 0.120 |
Why?
|
| Aged | 2 | 2017 | 956 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 567 | 0.110 |
Why?
|
| Nickel | 1 | 2014 | 6 | 0.110 |
Why?
|
| Cobalt | 1 | 2014 | 9 | 0.110 |
Why?
|
| Adult | 1 | 2017 | 794 | 0.110 |
Why?
|
| Male | 2 | 2017 | 1860 | 0.100 |
Why?
|
| Humans | 3 | 2017 | 2957 | 0.090 |
Why?
|
| Female | 1 | 2017 | 1724 | 0.090 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 5 | 0.090 |
Why?
|
| Calcineurin | 1 | 2011 | 6 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2011 | 97 | 0.080 |
Why?
|
| Inflammation | 1 | 2009 | 31 | 0.070 |
Why?
|
| Calcium Phosphates | 2 | 2005 | 11 | 0.070 |
Why?
|
| Models, Animal | 2 | 2005 | 54 | 0.070 |
Why?
|
| Cell Line | 3 | 2014 | 56 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2006 | 3 | 0.060 |
Why?
|
| Interleukins | 1 | 2006 | 6 | 0.060 |
Why?
|
| Animals | 4 | 2014 | 1050 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2006 | 9 | 0.060 |
Why?
|
| Durapatite | 1 | 2005 | 5 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2005 | 8 | 0.060 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2005 | 12 | 0.060 |
Why?
|
| Fracture Healing | 1 | 2005 | 13 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 37 | 0.060 |
Why?
|
| Implants, Experimental | 1 | 2005 | 25 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 59 | 0.050 |
Why?
|
| Bone Regeneration | 1 | 2005 | 58 | 0.050 |
Why?
|
| Mice | 2 | 2014 | 343 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2009 | 21 | 0.030 |
Why?
|
| Rats | 2 | 2005 | 234 | 0.030 |
Why?
|
| Femur | 2 | 2005 | 106 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2014 | 4 | 0.030 |
Why?
|
| Molybdenum | 1 | 2014 | 4 | 0.030 |
Why?
|
| Chromium | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cell Death | 1 | 2014 | 10 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 14 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 40 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 85 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 1 | 2011 | 4 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 9 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 22 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 26 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 45 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 47 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 53 | 0.020 |
Why?
|
| Apoptosis | 1 | 2009 | 36 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2009 | 29 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2006 | 4 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2006 | 5 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2006 | 9 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 21 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 33 | 0.010 |
Why?
|
| Femoral Fractures | 1 | 2005 | 9 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 2005 | 5 | 0.010 |
Why?
|
| Shear Strength | 1 | 2005 | 6 | 0.010 |
Why?
|
| Growth Substances | 1 | 2005 | 7 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 9 | 0.010 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2005 | 11 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 57 | 0.010 |
Why?
|
| Titanium | 1 | 2005 | 55 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 161 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 85 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 208 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2005 | 69 | 0.010 |
Why?
|